Ampio Pharmaceuticals
AMPE
#11315
Rank
โ‚น19.52 M
Marketcap
โ‚น17.20
Share price
0.00%
Change (1 day)
1,840.22%
Change (1 year)

Operating Margin for Ampio Pharmaceuticals (AMPE)

Operating Margin as of November 2026 (TTM): -7,347.71%

According to Ampio Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -7,347.71%. At the end of 2015 the company had an Operating Margin of -2,900.24%.

Operating Margin history for Ampio Pharmaceuticals from 2012 to 2015

Operating Margin at the end of each year

Year Operating Margin Change
2015-2,900.24%-94.3%
2014-50,853.58%3.66%
2013-49,056.85%111.58%
2012-23,186.23%-76.21%
2011-97,475.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-100.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.01%-100.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
18.02%-100.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
33.25%-100.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Rigel Pharmaceuticals
RIGL
41.39%-100.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-79.07%-98.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-10.86%-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.